Literature DB >> 27032509

Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors.

Ahmed A H Abdellatif1, Gamal Zayed1, Asmaa El-Bakry2, Alaa Zaky2, Imran Y Saleem3, Hesham M Tawfeek4.   

Abstract

Targeting of G-protein coupled receptors (GPCRs) like somatostatin-14 (SST-14) could have a potential interest in delivery of anti-cancer agents to tumor cells. Attachment of SST to different nano-carriers e.g. polymeric nanoparticles is limited due to the difficulty of interaction between SST itself and those nano-carriers. Furthermore, the instability problems associated with the final formulation. Attaching of SST to gold nanoparticles (AuNPs) using the positive and negative charge of SST and citrate-AuNPs could be considered a new technique to get stable non-aggregated AuNPs coated with SST. Different analyses techniques have been performed to proof the principle of coating between AuNPs and SST. Furthermore, cellular uptake studies on HCC-1806, HELA and U-87 cell lines has been investigated to show the ability of AuNPs coated SST to enter the cells via SST receptors. Dynamic light scattering (DLS) indicated a successful coating of SST on the MUA-AuNPs surface. Furthermore, all the performed analysis including DLS, SDS-PAGE and UV-VIS absorption spectra indicated a successful coating of AuNPs with SST. Cellular uptake studies on HCC-1806, HELA and U-87 cell lines showed that the number of AuNPs-SST per cell is signiflcantly higher compared to citrate-AuNPs when quantified using inductively coupled plasma spectroscopy. Moreover, the binding of AuNPs-SST to cells can be suppressed by addition of antagonist, indicating that the binding of AuNPs-SST to cells is due to receptor-specific binding. In conclusion, AuNPs could be attached to SST via adsorption to get stable AuNPs coated SST. This new formulation has a potential to target SST receptors localized in many normal and tumor cells.

Entities:  

Keywords:  Citrate gold nanoparticles; HCC-1806 cell lines; nanoparticles targeting; somatostatin acetate; somatostatin targeting

Mesh:

Substances:

Year:  2016        PMID: 27032509     DOI: 10.3109/03639045.2016.1173052

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  12 in total

1.  Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities.

Authors:  Ahmed A H Abdellatif; Hamad N H Alturki; Hesham M Tawfeek
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

2.  Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7.

Authors:  Ahmed A H Abdellatif; Zafar Rasheed; Ahmad H Alhowail; Abdulmajeed Alqasoumi; Mansour Alsharidah; Riaz A Khan; Abdullah S M Aljohani; Maha A Aldubayan; Waleed Faisal
Journal:  Int J Nanomedicine       Date:  2020-10-30

3.  Low-density lipoprotein encapsulated thiosemicarbazone metal complexes is active targeting vehicle for breast, lung, and prostate cancers.

Authors:  Laila Jaragh-Alhadad; Mayada Samir; Terri J Harford; Sadashiva Karnik
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 4.  Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma.

Authors:  Min Li; Weiyue Zhang; Birong Wang; Yang Gao; Zifang Song; Qi Chang Zheng
Journal:  Int J Nanomedicine       Date:  2016-10-31

5.  Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors.

Authors:  Ahmed Abdelfattah Hafez Abdellatif; Wael Abdellah Abdelhafez; Hatem Abdelmunsef Sarhan
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

Review 6.  Somatostatin receptors as a new active targeting sites for nanoparticles.

Authors:  Ahmed A H Abdellatif; Sa'ed M Aldalaen; Waleed Faisal; Hesham M Tawfeek
Journal:  Saudi Pharm J       Date:  2018-05-31       Impact factor: 4.330

7.  Targeting of somatostatin receptors expressed in blood cells using quantum dots coated with vapreotide.

Authors:  Ahmed A H Abdellatif; Heba A Abou-Taleb; Ahmed A Abd El Ghany; Ilka Lutz; Abdellatif Bouazzaoui
Journal:  Saudi Pharm J       Date:  2018-07-20       Impact factor: 4.330

Review 8.  Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants.

Authors:  Abdellatif Bouazzaoui; Ahmed A H Abdellatif; Faisal A Al-Allaf; Neda M Bogari; Saied Al-Dehlawi; Sameer H Qari
Journal:  Pharmaceutics       Date:  2021-01-22       Impact factor: 6.321

9.  The Anti-Inflammatory Effect of a γ-Lactone Isolated from Ostrich Oil of Struthio camelus (Ratite) and Its Formulated Nano-Emulsion in Formalin-Induced Paw Edema.

Authors:  Salah E M Eltom; Ahmed A H Abdellatif; Hamzah Maswadeh; Mohsen S Al-Omar; Atef A Abdel-Hafez; Hamdoon A Mohammed; Eiman Me Agabein; Ibrahim Alqasoomi; Salem A Alrashidi; Mohammed S M Sajid; Mugahid A Mobark
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411

10.  Cetuximab Conjugated with Octreotide and Entrapped Calcium Alginate-beads for Targeting Somatostatin Receptors.

Authors:  Ahmed A H Abdellatif; Mohamed A Ibrahim; Mohammed A Amin; Hamzah Maswadeh; Muhammed N Alwehaibi; Sultan N Al-Harbi; Zayed A Alharbi; Hamdoon A Mohammed; Ahmed B M Mehany; Imran Saleem
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.